Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2015-09-15 to 2024-05-09
Current total value of award: $501635.75
Description: VADIS TRIAL:  PHASE II TRIAL OF E75 PEPTIDE VACCINE IN WOMEN WITH DCIS OF THE BREAST